| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,705,000 | 4,003,000 | 5,387,000 | 3,586,000 | | Cost of Revenue | 2,429,000 | 2,595,000 | 4,654,000 | 1,322,000 | | | Gross Profit | 1,276,000 | 1,408,000 | 733,000 | 2,264,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 284,000 | 285,000 | (952,000) | 1,592,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 409,000 | 371,000 | 369,000 | 358,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 583,000 | 752,000 | 1,316,000 | 314,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11,000) | (114,000) | 62,000 | 15,000 | | Earnings Before Interest And Taxes | 579,000 | 731,000 | 1,338,000 | 355,000 | | Interest Expense | 196,000 | 216,000 | 204,000 | 194,000 | | Income Before Tax | 383,000 | 515,000 | 1,134,000 | 161,000 | | Income Tax Expense | 19,000 | 108,000 | 360,000 | (48,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 364,000 | 407,000 | 774,000 | 209,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 364,000 | 407,000 | 774,000 | 209,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $364,000 | $407,000 | $774,000 | $209,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
